导航
| 股票代码 | 股票名称 | 仓位比例 | 涨跌 | 贡献增长率 |
| 603259 | 药明康德 | 9.16% | -0.96% | -0.0879% |
| 01801 | 信达生物 | 9.13% | -1.68% | -0.1534% |
| 600276 | 恒瑞医药 | 8.89% | 0.26% | 0.0231% |
| 01530 | 三生制药 | 8.07% | 0.46% | 0.0371% |
| 06990 | 科伦博泰生 | 6.07% | -0.86% | -0.0522% |
| 002294 | 信立泰 | 4.65% | -0.05% | -0.0023% |
| 01093 | 石药集团 | 3.65% | 0.00% | 0.0000% |
| 02268 | 药明合联 | 3.60% | -4.21% | -0.1516% |
| 02162 | 康诺亚-B | 3.44% | -0.72% | -0.0248% |
| 06127 | 昭衍新药 | 2.84% | 0.82% | 0.0233% |
| 重仓股合计:59.5%, 重仓股贡献增长率: -0.3887%, 总持股仓位:86.07%,修正增长率: | ||||
| 日期 | 实际增长率 | 预估增长率 |
| 2025-12-19 | 2.00% | 1.48% |
| 2025-12-18 | -0.36% | -0.19% |
| 2025-12-17 | 1.02% | 1.21% |
| 2025-12-16 | -1.55% | -1.48% |
| 2025-12-15 | -3.03% | -2.48% |
| 2025-12-12 | 1.48% | 0.86% |
| 2025-12-11 | 0.28% | -0.14% |
| 2025-12-10 | -0.21% | -0.31% |
| 基金名称 | 单位净值 | 增长率 |
| 华商优势行业混合 | 1.8743 | 3.8377% |
| 华商均衡成长混合A | 1.9958 | 3.7890% |
| 华商均衡成长混合C | 1.9404 | 3.7890% |
| 华商致远回报混合A | 1.6735 | 3.0602% |
| 华商致远回报混合C | 1.6692 | 3.0602% |
| 华商龙头优势混合 | 1.6035 | 3.0333% |
| 华商高端装备制造股票A | 3.8899 | 2.9628% |
| 华商智能生活灵活配置混合A | 1.9815 | 2.8829% |
| 华商新兴活力混合 | 2.0451 | 2.8725% |
| 华商远见价值A | 0.7648 | 2.7671% |
| 基金名称 | 单位净值 | 增长率 |
| 财通集成电路产业股票A | 3.9493 | 5.4097% |
| 财通集成电路产业股票C | 3.7329 | 5.4097% |
| 创金合信专精特新股票发起A | 1.7152 | 4.0629% |
| 创金合信专精特新股票发起C | 1.6821 | 4.0629% |
| 信澳转型创新股票A | 1.4432 | 4.0553% |
| 信澳转型创新股票C | 1.4131 | 4.0553% |
| 国泰金鑫股票C | 3.0389 | 3.9677% |
| 国泰金鑫股票A | 3.1105 | 3.9677% |
| 同泰数字经济股票A | 1.1700 | 3.9549% |
| 同泰数字经济股票C | 1.1495 | 3.9549% |
